Dr. Cassaidy is a postdoctoral fellow in medicine design at Pfizer,  studying saRNA delivery to cells. Before joining Pfizer, she completed her Ph.D. at the University of Chicago in 2022 in Molecular Engineering with the Esser-Kahn lab, performing research on single dose vaccines, trained immunity, and controlled release formulations for NF-kB inhibitors. Prior to her doctoral studies, Dr. Cassaidy attended Iowa State University in Ames, Iowa, as a chemistry major where she first performed plant exudate research with Prof Lori Biederman. Interested in making molecules, Britteny worked under Prof Brett VanVeller researching cell-penetrating peptides. She received her BS in 2016.

Dr. Kattan is a postdoc fellow at AbbVie in Research Pharmacology. She earned her PhD in Development and Cell Biology from University of California – Irvine in 2023. Her doctoral research included projects on characterization of Hippo pathway WW domain binding and defining protein protein interaction network of human protein phospholipase D superfamily. Prior to her doctoral training, Dr. Kattan, completed her Mater in Science training in Chemistry at University of California, Los Angeles, and her bachelors in Biochemistry in 2015 from California State University, Fullerton.  

Dr. Kyra Laubach received her PhD in Integrative Pathobiology from the University of California, Davis and her B.S. in Biology from Cal Poly San Luis Obispo. Her PhD work was centered in cancer biology and leveraging multi-omic approaches to study the intersection of oncogenesis and metabolism. Kyra is currently working on her postdoctoral training at AbbVie in South San Francisco, where she is part of both Computational Oncology and Immuno-Oncology within discovery sciences.